Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme

Faecal immunochemical testing (FIT) for colorectal cancer (CRC) screening has suboptimal sensitivity for detecting advanced neoplasia. To increase its performance, FIT could be combined with other risk factors.

[1]  E. Dekker,et al.  Colorectal cancer screening by colonoscopy: putting it into perspective , 2016, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[2]  S. Berndt,et al.  Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. , 2015, Gastroenterology.

[3]  T. Lash,et al.  Familial colorectal cancer risk may be lower than previously thought: a Danish cohort study. , 2015, Cancer epidemiology.

[4]  A. Zauber,et al.  The impact of stratifying by family history in colorectal cancer screening programs , 2015, International journal of cancer.

[5]  E. Kuipers,et al.  Colorectal cancer screening: a global overview of existing programmes , 2015, Gut.

[6]  P. Bossuyt,et al.  Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. , 2015, Cancer epidemiology.

[7]  P. Bossuyt,et al.  Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer , 2015, Familial Cancer.

[8]  P. Kongkam,et al.  A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants. , 2015, Gastrointestinal endoscopy.

[9]  Douglas K. Rex,et al.  Quality Indicators for Colonoscopy , 2006, Gastrointestinal endoscopy.

[10]  D. Nicolás-Pérez,et al.  Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. , 2014, Gastroenterology.

[11]  R. Molina,et al.  Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. , 2014, Gastroenterology.

[12]  K. Hughes,et al.  Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Christian Stock,et al.  Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. , 2014, Gastroenterology.

[14]  T. Levin,et al.  Accuracy of Fecal Immunochemical Tests for Colorectal Cancer , 2014, Annals of Internal Medicine.

[15]  E. Kuipers,et al.  Risk factors for false positive and for false negative test results in screening with fecal occult blood testing , 2013, International journal of cancer.

[16]  Justin C.Y. Wu,et al.  Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer , 2013, Alimentary pharmacology & therapeutics.

[17]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[18]  E. Kuipers,et al.  Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy , 2013, Gut.

[19]  C. Shun,et al.  Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  F. Nagengast,et al.  Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[21]  Chyke A Doubeni,et al.  Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults , 2013, Annals of Internal Medicine.

[22]  Justin C.Y. Wu,et al.  Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. , 2013, Gastroenterology.

[23]  J. Cha,et al.  First-Degree Relatives of Colorectal Cancer Patients Are Likely to Show Advanced Colorectal Neoplasia despite a Negative Fecal Immunochemical Test , 2012, Digestion.

[24]  E. Kuipers,et al.  Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia , 2012, The American Journal of Gastroenterology.

[25]  J. Habbema,et al.  Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening , 2012, Gut.

[26]  Paul Fockens,et al.  Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. , 2012, The Lancet. Oncology.

[27]  G. Meijer,et al.  Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand , 2012, BMC Cancer.

[28]  Paul Fockens,et al.  Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial , 2011, Gut.

[29]  M. V. van Oijen,et al.  Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. , 2011, European journal of cancer.

[30]  F. Armelao,et al.  Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening program. , 2011, Gastrointestinal endoscopy.

[31]  Roderik A Kraaijenhagen,et al.  Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study , 2011, Vascular health and risk management.

[32]  E. Kuipers,et al.  protocolStudy protocol : population screening for colorectal cancer by colonoscopy or CT colonography : a randomized controlled trial , 2010 .

[33]  J. Habbema,et al.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy , 2009, Gut.

[34]  Douglas K Rex,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2022 .

[35]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[36]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[37]  H. Brenner,et al.  Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies , 2007, Gut.

[38]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[39]  H. Vasen,et al.  The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. , 2006, The Netherlands journal of medicine.

[40]  S. Cole,et al.  Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer , 2006, European journal of gastroenterology & hepatology.

[41]  D. Faigel,et al.  ASGE guideline: colorectal cancer screening and surveillance. , 2006, Gastrointestinal endoscopy.

[42]  P. Boyle,et al.  Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. , 2006, Journal of clinical epidemiology.

[43]  Julian P T Higgins,et al.  Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. , 2006, European journal of cancer.

[44]  D. Weinberg,et al.  Narrative Review: Screening for Colorectal Cancer in Patients with a First-Degree Relative with Colonic Neoplasia , 2005, Annals of Internal Medicine.

[45]  E. Stoffel,et al.  Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[46]  Les Irwig,et al.  Assessing the gain in diagnostic performance when combining two diagnostic tests , 2002, Statistics in medicine.

[47]  R. Houlston,et al.  A systematic review and meta-analysis of familial colorectal cancer risk , 2001, American Journal of Gastroenterology.

[48]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[49]  L. Sobin,et al.  Colon and Rectum , 1998 .

[50]  Aaron Sloman,et al.  The evolution of what , 1998 .

[51]  T. Muto,et al.  The evolution of cancer of the colon and rectum , 1975, Cancer.